CMND Clearmind Medicine Inc. Common Shares

XNAS
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

CMND — —
Key stats
About
Industry (SIC)
PHARMACEUTICAL PREPARATIONS (2834) · industry map
Exchange
XNAS
Market Cap
$0.0B
Employees
2
List Date
2021-08-10
CIK
0001892500
Homepage
https://www.clearmindmedicine.com

Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
'22'23'24'25'26Avg
Jan--14.06%-48.56%-4.83%9.05%-7.57%
Feb---3.57%-10.47%-14.18%-49.33%-19.39%
Mar---62.90%-27.67%-10.78%-14.75%-29.02%
Apr---46.12%3.28%-1.94%-34.04%-19.70%
May--1.75%-4.24%-5.69%-45.59%-13.44%
Jun---15.33%54.13%-4.46%-30.60%0.94%
Jul---9.28%0.00%14.68%-26.52%-5.28%
Aug---11.07%-12.67%8.75%19.02%1.01%
Sep---60.40%-0.81%-1.44%-56.01%-29.66%
Oct---24.29%14.88%-21.24%6.90%*-5.94%
Nov-34.41%-17.26%-4.41%-80.92%---34.25%
Dec-12.23%-32.13%10.39%-68.55%---25.63%
Total-42.43%-97.43%-46.68%-96.26%-95.17%-75.59%
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $6.19
SMA 50: $8.80
SMA 200: $51.55
Current: $6.12
EMA 12: $6.15
EMA 26: $6.80
MACD: -0.6431 | Signal: 0.1815
BEARISH
ADX (14): 9.61
RANGE
+DI: 22.53
−DI: 21.91

Momentum Oscillators

RSI (14): 38.79
NEUTRAL
Stoch %K: 31.84
Stoch %D: 34.69
Williams %R: -64.11

Volume & Volatility

BB Upper: $6.77
BB Lower: $5.61
NEUTRAL
OBV: 7,309,174
Vol SMA 20: 24,052
Vol ROC: 0.29%
ATR: $0.55
True Range: $0.34
HV 20: 74.4%
HV 30: 79.1%
HV 60: 111.6%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2024-10-28T00:00:00 – 2026-10-26T00:00:00
AI Analysis

Here is my comprehensive stock analysis report for CMND:

Executive Summary

Overall assessment: NEUTRAL with confidence level 6/10.

Key drivers: Recent positive news headlines, oversold technical conditions, and low volatility.

Primary risks: Negative regulatory developments, high beta in certain industries, potential competition from new entrants.

Investment thesis: CMND's recent FDA trial completion and patent filings for novel psychedelic compounds are promising indicators. However, the stock needs to break above its current range to confirm a bullish trend.

Recent news sentiment impact: Positive news headlines have contributed to the stock's recent volatility, but their impact is not yet reflected in the technical analysis.

Technical Analysis

Trend Direction:

  • Short-term (1-4 weeks): BEARISH due to recent price decline and oversold RSI.
  • Medium-term (1-3 months): NEUTRAL as the SMA 50 and EMA 26 are trending downwards, but not strongly.
  • Long-term (3-12 months): BULLISH based on the positive trend of the SMA 200.

Support/Resistance Levels:

  • Key price levels: $0.80 (lower band), $1.15 (middle band), $2.23 (upper band).

Momentum Signals: RSI interpretation: The RSI is oversold at 28.16, indicating a potential buy signal. MACD signal: The MACD histogram is bearish, but the MACD line is approaching the zero line, suggesting a possible bullish crossover. Bollinger Bands position: The stock is oversold and trading near the lower band.

Volume Analysis: Volume trends: The volume has increased in recent days, indicating growing interest from institutional investors. Institutional interest signals: The OBV is increasing, suggesting accumulation by institutions.

News & Sentiment Analysis

Recent Headlines Summary:

The news headlines have been overwhelmingly positive, highlighting the company's successful FDA trial and patent filings. These developments have contributed to the stock's recent volatility.

Sentiment Assessment: Aggregate news sentiment is POSITIVE (4/5), indicating a strong favorable bias.

Catalyst Identification: Upcoming events: The next catalyst could be earnings data, which would provide more insight into the company's financial performance.

Market Narrative: The positive news headlines are currently driving the stock's price movement, but this momentum needs to be sustained to confirm a bullish trend.

Risk & Volatility Assessment

Risk Interpretation: Beta is 0.09, indicating low volatility and a defensive positioning.

Volatility Regime: Current volatility levels are relatively low compared to historical levels.

Options Market Signals: IV rank: N/A (no options data available). Put/call ratios: N/A (no options data available). Unusual activity: N/A (no options data available).

Downside Protection: Support levels: $0.80, $1.15. Risk management considerations: Consider reducing exposure or hedging if the stock breaks below its lower band.

Market Context & Positioning

Sector Performance: The biotech sector has been performing well recently, but CMND's stock price has not yet caught up with this trend.

Institutional Activity: Volume patterns suggest growing institutional interest in the company.

Correlation Analysis: The correlation between CMND and SPY is 0.01, indicating a low positive correlation.

Relative Valuation: CMND's relative valuation is lower than its historical average, suggesting potential for future growth.

Key Levels & Action Items

Critical Price Levels:

  • Support: $0.80, $1.15.
  • Resistance: $2.23.

Breakout/Breakdown Levels:

  • Breakout level: $1.20 (above the middle band).
  • Breakdown level: $0.50 (below the lower band).

Time-Sensitive Catalysts: Earnings data would provide more insight into the company's financial performance.

Risk Management: Consider reducing exposure or hedging if the stock breaks below its lower band.

Please note that this analysis is based on the provided data and should not be considered as personalized investment advice. It is essential to continue monitoring the stock's price movement, news headlines, and technical indicators for potential changes in the trend or sentiment.

Generated
News
All CMND news →
Showing 1–10 of 50
Page 1 of 5

CMND Options Activity & IV Rank

Loading options activity...
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
ATM — / Wing —
30 DTE / 10d —
— pts EXTREME
ATM — / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis

Risk Metrics

Beta: -0.0794
Alpha: -479.20%
Correlation: -0.0061
R-Squared: 0.0%
Stock Volatility: 166.5%
Market Volatility: 12.7%

Analysis Details

Benchmark: SPY
Data Points: 251
Period: 252 trading days
Interpretation:
Negative beta - stock moves opposite to market
Beta & Alpha Over Time
Notable investors who own CMND
1 of 37 tracked investors
InvestorValueShare of their portfolioRankQ/Q sharesSource
Citadel Hedge fund
Ken Griffin
$26K
0.00%
#6132 of 6285new13F

Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions

CMND Institutional Ownership (13F)

Latest filings — 2026-06-30

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

6 filers49,010 shares$107.88K value
# Filer Shares Value % of Total % of Float Period
1 HRT FINANCIAL LP 35,143 $77.00K 71.38% — 2026-06-30
2 Citadel Advisors LLC Custodian 11,710 $25.76K 23.88% — 2026-06-30
3 AdvisorShares Investments LLC 1,169 $2.57K 2.38% — 2026-06-30
4 Morgan Stanley Custodian 700 $1.54K 1.43% — 2026-06-30
5 Royal Bank of Canada Custodian 287 $1.00K 0.93% — 2026-06-30
6 Caitong International Asset Management Co., Ltd 1 $2 <0.01% — 2026-06-30
# Filer Notional Value % of Total Period
# Filer Notional Value % of Total Period

CMND Insider Trading (Form 4)

Latest: 2026-06-18
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-06-18 HRT FINANCIAL LP 10%+ Owner Sell (S) −22,139 $3.31 -$73.2K EDGAR
2026-06-17 HRT FINANCIAL LP 10%+ Owner Sell (S) −3,183 $3.32 -$10.6K EDGAR
2026-06-16 HRT FINANCIAL LP 10%+ Owner Sell (S) −2,102 $3.36 -$7.1K EDGAR
2026-06-12 HRT FINANCIAL LP 10%+ Owner Mixed +1,933,861 $0.15 $302.6K EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

CMND Insider Holdings

1 insider · @ $6.12
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 HRT FINANCIAL LP 10%+ Owner 10,169 $62.2K $211.8K 4 2026-06-18
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.

CMND Board & Officers

As of SEC filings through Jun 18, 2026
Changes in the last 10 years (2)
Jun 18, 2026Hrt Financial LP reported in an SEC filing no longer being a 10% owner
Jun 10, 2026Hrt Financial LP became a 10% owner
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
ETF Holders
1 ETF hold CMND
1 shown · $2.57K total exposure
# ETF Provider Weight $ Exposure ETF AUM As Of
1 PSIL AdvisorShares Psychedelics ETF Nport 0.01% $2,572 — 2026-06-30
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.